A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes : The INFINITY Study

المؤلفون المشاركون

Khithani, Anil
de Carolis, Emidio
Balleza, Lyn
Vira, Tasnim
Madan, Mina
Rampakakis, Emmanouil
Sampalis, John
Boukas, Stella
Gupta, Anup
Vaillancourt, Julie

المصدر

Advances in Preventive Medicine

العدد

المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-11، 11ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2012-12-06

دولة النشر

مصر

عدد الصفحات

11

التخصصات الرئيسية

الصحة العامة

الملخص EN

Background.

There is a paucity of data regarding the effectiveness and safety of lipid-lowering treatments among South-Asian patients.

Methods.

Sixty-four South-Asian Canadians with coronary artery disease or diabetes and persistent hypercholesterolemia on statin therapy, were randomized to ezetimibe 10 mg/day co-administered with statin therapy (EZE + Statin) or doubling their current statin dose (STAT2).

Primary outcome was the proportion of patients achieving target LDL-C (<2.0 mmol/L) after 6 weeks.

Secondary outcomes included the change in lipid profile and the incidence of treatment-emergent adverse events through 12 weeks.

Exploratory markers for vascular inflammation were assessed at baseline and 12 weeks.

Results.

At 6 weeks, the primary outcome was significantly higher among the EZE + Statin patients (68% versus 36%; P=0.031) with an OR (95% CI) of 3.97 (1.19, 13.18) upon accounting for baseline LDL-C and adjusting for age.

At 12 weeks, 76% of EZE + Statin patients achieved target LDL-C compared to 48% (P=0.047) of the STAT2 patients (adjusted OR (95% CI) = 3.31 (1.01,10.89)).

No significant between-group differences in exploratory markers were observed with the exception of CRP.

Conclusions.

Patients receiving ezetimibe and statin were more likely to achieve target LDL-C after 6 and 12 weeks compared to patients doubling their statin dose.

Ezetimibe/statin combination therapy was well tolerated among this cohort of South-Asian Canadians, without safety concerns.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Madan, Mina& Vira, Tasnim& Rampakakis, Emmanouil& Gupta, Anup& Khithani, Anil& Balleza, Lyn…[et al.]. 2012. A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes : The INFINITY Study. Advances in Preventive Medicine،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-446605

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Madan, Mina…[et al.]. A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes : The INFINITY Study. Advances in Preventive Medicine No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-446605

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Madan, Mina& Vira, Tasnim& Rampakakis, Emmanouil& Gupta, Anup& Khithani, Anil& Balleza, Lyn…[et al.]. A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes : The INFINITY Study. Advances in Preventive Medicine. 2012. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-446605

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-446605